Trial intelligence / Profile preview

LLLT, HA, Ozone, and Methylprednisolone for Post-Extraction Complications

NCT06900907Completed

Sponsor
Batman University
Start
Mar 2017
Primary completion
Aug 2017
Modality
Polymer-based Nanoparticles, Recombinant Proteins and Enzymes, Orthosteric Ligands
Countries
1
01

Overview

Randomised, single-blind trial of methylprednisolone, hyaluronic acid and medical ozonated water in impacted tooth (5 arms), sponsored by Batman University. Primary endpoint: Trismus at 7 days. Started Mar 2017; status: completed.

02

Drugs

methylprednisolonehyaluronic acidmedical ozonated water
03

Conditions

impacted tooth

Beyond the preview

Go deeper on NCT06900907.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06900907.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call